Snowden Capital Advisors’s Crinetics Pharmaceuticals CRNX Stock Holding History

Snowden Capital Advisors’s Portfolio CRNX Stock Details CRNX Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell
2025 Q4	$217K	Sell
2025 Q3	$203K	Buy
2025 Q1	–	Sell
2024 Q4	$265K	Buy
2024 Q3	$263K	Buy
2024 Q2	$225K	Sell
2024 Q1	$240K	Buy